-
公开(公告)号:AU8107182A
公开(公告)日:1982-09-09
申请号:AU8107182
申请日:1982-03-03
Applicant: TORAY INDUSTRIES
Inventor: OHNO KIYOTAKA , NAGASE HIROSHI , ISHIKAWA MAMORU , MATSUMOTO KAZUHISA , NISHIO SHINTARO
IPC: A61K31/34 , A61K31/343 , A61K31/557 , A61K31/5575 , A61P43/00 , C07C17/093 , C07C29/00 , C07C29/17 , C07C51/16 , C07C405/00 , C07D307/93 , C07D307/937 , C07D309/12 , C07D405/12 , C07D407/12 , C07D493/04 , C07F7/18 , C07D405/14 , C07D409/12 , C07D409/14
Abstract: Pharmaceutically useful compounds are 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives such as 5,6,7-trinor-4,8-inter-m-phenylene-13,14-didehydro PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-16,16-dimethyl PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17- alpha -methyl-20-homo PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17,18,19,20-tetranor-16-phenoxy PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-20-isopropylidene PGI2, 5,6,7-trinor-4,8-inter-(5-methyl-1,3-phenylene) PGI2, and 5,6,7-trinor-4,8-inter-m-phenylene-2,3-didehydro-16,17,18,19,20-pentan or-15-phenyl PGI2. They are useful in treatment of ulcers, thrombii and hypertension for example.
-
2.
公开(公告)号:DE3267350D1
公开(公告)日:1985-12-19
申请号:DE3267350
申请日:1982-03-01
Applicant: TORAY INDUSTRIES
Inventor: OHNO KIYOTAKA , NAGASE HIROSHI , ISHIKAWA MAMORU , MATSUMOTO KAZUHISA , NISHIO SHINTARO
IPC: A61K31/34 , A61K31/343 , A61K31/557 , A61K31/5575 , A61P43/00 , C07C17/093 , C07C29/00 , C07C29/17 , C07C51/16 , C07C405/00 , C07D307/93 , C07D307/937 , C07D309/12 , C07D405/12 , C07D407/12 , C07D493/04 , C07F7/18 , C07D407/00
Abstract: Pharmaceutically useful compounds are 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives such as 5,6,7-trinor-4,8-inter-m-phenylene-13,14-didehydro PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-16,16-dimethyl PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17- alpha -methyl-20-homo PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17,18,19,20-tetranor-16-phenoxy PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-20-isopropylidene PGI2, 5,6,7-trinor-4,8-inter-(5-methyl-1,3-phenylene) PGI2, and 5,6,7-trinor-4,8-inter-m-phenylene-2,3-didehydro-16,17,18,19,20-pentan or-15-phenyl PGI2. They are useful in treatment of ulcers, thrombii and hypertension for example.
-
公开(公告)号:AU560140B2
公开(公告)日:1987-04-02
申请号:AU8107182
申请日:1982-03-03
Applicant: TORAY INDUSTRIES
Inventor: OHNO KIYOTAKA , NAGASE HIROSHI , ISHIKAWA MAMORU , MATSUMOTO KAZUHISA , NISHIO SHINTARO
IPC: A61K31/34 , A61K31/343 , A61K31/557 , A61K31/5575 , A61P43/00 , C07C17/093 , C07C29/00 , C07C29/17 , C07C51/16 , C07C405/00 , C07D307/93 , C07D307/937 , C07D309/12 , C07D405/12 , C07D407/12 , C07D493/04 , C07F7/18 , C07D405/14 , C07D409/12 , C07D409/14
Abstract: Pharmaceutically useful compounds are 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives such as 5,6,7-trinor-4,8-inter-m-phenylene-13,14-didehydro PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-16,16-dimethyl PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17- alpha -methyl-20-homo PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-17,18,19,20-tetranor-16-phenoxy PGI2, 5,6,7-trinor-4,8-inter-m-phenylene-20-isopropylidene PGI2, 5,6,7-trinor-4,8-inter-(5-methyl-1,3-phenylene) PGI2, and 5,6,7-trinor-4,8-inter-m-phenylene-2,3-didehydro-16,17,18,19,20-pentan or-15-phenyl PGI2. They are useful in treatment of ulcers, thrombii and hypertension for example.
-
4.
公开(公告)号:JP2003192640A
公开(公告)日:2003-07-09
申请号:JP2001393473
申请日:2001-12-26
Applicant: TORAY INDUSTRIES
Inventor: NISHIMURA KAZUAKI , YAMAKAWA SHINOBU , ISHIKAWA MAMORU
IPC: C07C67/52 , C07C67/54 , C07C69/732
Abstract: PROBLEM TO BE SOLVED: To profitably obtain granular optically active methyl phenyllactate from an optically active methyl phenyllactate solution obtained by a reaction without concentrating and drying the optically active methyl phenyllactate solution, without crystallizing the compound, and without causing a trouble on operation and a complicated problem. SOLUTION: This granular optically active methyl phenyllactate is obtained by concentrating the organic solvent solution of the optically active methyl phenyllactate at a liquid temperature of ≤150°C and then granulating the melted optically active methyl phenyllactate with a granulating machine. COPYRIGHT: (C)2003,JPO
-
公开(公告)号:JP2003192633A
公开(公告)日:2003-07-09
申请号:JP2001393471
申请日:2001-12-26
Applicant: TORAY INDUSTRIES
Inventor: NISHIMURA KAZUAKI , ISHIKAWA MAMORU
IPC: C07C51/367 , C07C51/43 , C07C59/11
Abstract: PROBLEM TO BE SOLVED: To eliminate the need for complicated separation and recovery and to industrially advantageously provide an optically active phenyllactic acid without using a mixed solvent for crystallizing the optically active phenyllactic acid when diazotizing and hydrolyzing an optically active phenylalanine and obtaining the produced optically active phenyllactic acid. SOLUTION: The optically active phenylalanine is diazotized and hydrolyzed to obtain the resultant optically active phenyllactic acid. In the process, the optically active phenyllactic acid is crystallized from toluene solution and separated. The optically active phenylalanine is diazotized and hydrolyzed to extract the resultant reactional mixture containing the produced optically active phenyllactic acid with an organic solvent other than the toluene. The solvent is then replaced with the toluene. COPYRIGHT: (C)2003,JPO
-
公开(公告)号:JP2001192363A
公开(公告)日:2001-07-17
申请号:JP2000316605
申请日:2000-10-17
Applicant: TORAY INDUSTRIES
Inventor: SUEMATSU MASAAKI , MATSUOKA SHOTARO , ISHIKAWA MAMORU
IPC: B01J31/20 , C07B61/00 , C07C253/30 , C07C255/57
Abstract: PROBLEM TO BE SOLVED: To provide a method for producing cyanobenzoic acid in high yield by liquid-phase air oxidation of cyano group-bearing aromatic hydrocarbon. SOLUTION: This liquid-phase air oxidation is carried out in the presence of a catalyst containing a cobalt compound, zirconia and a bromine compound.
-
公开(公告)号:JPH08309197A
公开(公告)日:1996-11-26
申请号:JP11995195
申请日:1995-05-18
Applicant: TORAY INDUSTRIES
Inventor: MAEDA SHU , WATANABE MASATOSHI , ISHIKAWA MAMORU
IPC: B01J29/06 , B01J29/076 , B01J29/18 , B01J29/26 , C07B61/00 , C07C17/358 , C07C25/02
Abstract: PURPOSE: To carry out isomerization of an aromatic halide and lessen the loss by employing an acid type zeolite catalyst which is treated with boric acid trialkyl ester. CONSTITUTION: This acid type zeolite catalyst is produced by immersing and/or kneading an acid type zeolite with trialkyl borate. An aromatic halide is isomerized by bringing into contact with the acid type zeolite catalyst. As the acid type zeolite, any zeolite may be used, and a mordenite type zeolite, β-type zeolite, pentacyl-type zeolite, etc., are preferable. In the case of isomerization of dichlorotoluene, for example, a mordenite type zeolite is especially preferable. Not only a side reaction is suppressed to lessen the loss, but also selectively of the isomerization reaction is improved by employing the catalyst. Further, it is preferable that the trialkyl group of borate in the acid type zeolite is trimethyl and also rhenium is contained.
-
公开(公告)号:JPH08291096A
公开(公告)日:1996-11-05
申请号:JP9818395
申请日:1995-04-24
Applicant: TORAY INDUSTRIES
Inventor: SUZUKI MIYO , MORIMOTO MASAO , ISHIKAWA MAMORU
Abstract: PURPOSE: To separate a high-purity ethyl phenol isomer in a high yield by using a specific adsorbent, adsorbing and separating a prescribed isomer useful as an intermediate for a medicine, a color coupler, etc., from an ethylphenol isomer mixture. CONSTITUTION: A prescribed ethylphenol isomer is adsorbed on and separated from (B) an ethylphenol isomer mixture by using (A) an X type zeolite adsorbent (e.g. containing a metal such as Li, K, Rb, Cs, Mg, Ca, Sr, Ba, Pb, etc., and 1-10wt.% of water based on the adsorbent). For example, a mixture comprising m-ethylphenol (B1 ), p-ethylphenol (B2 ) and one or more alkyl phenols is used as the component B, the component B1 is adsorbed on and separated from the component B containing the component B1 , the component B2 and one or more alkylphenols by using the component B containing Mg, Ca or Sr and the component B2 is adsorbed on and separated from the component B by using the component B containing K or Ba.
-
公开(公告)号:JPH08245457A
公开(公告)日:1996-09-24
申请号:JP5624395
申请日:1995-03-15
Applicant: TORAY INDUSTRIES
Inventor: SUZUKI MIYO , MORIMOTO MASAO , ISHIKAWA MAMORU
Abstract: PURPOSE: To separate the subject isomer useful as a medicine intermediate, a color coupler or a polymer-modifying agent from an isomer mixture in a high purity and in a good yield by bringing the isomer mixture of an alkylphenol into contact with a specific adsorbent. CONSTITUTION: (A) An alkylphenol isomer mixture (e.g. an ethylphenol isomer mixture containing m-ethylphenol and p-ethylphenol) is brought into contact with (B) a lead-containing faujasite type zeolite adsorbent (e.g. a Y type zeolite adsorbent containing lead and calcium) to separate the objective isomer. A >=4C aliphatic alcohol is preferably used as a desorbing agent on the adsorption separation.
-
公开(公告)号:JPH07173095A
公开(公告)日:1995-07-11
申请号:JP31755693
申请日:1993-12-17
Applicant: TORAY INDUSTRIES
Inventor: MIYATA AKIRA , HONDA HIROAKI , ISHIKAWA MAMORU
IPC: C07B61/00 , C07C45/46 , C07C49/76 , C07C49/782
Abstract: PURPOSE:To provide a process for acylating aromatic hydrocarbons, aliphatic and aromatic carboxylic acids and their derivatives in high conversion, high regioselectivity and high efficiency. CONSTITUTION:An acylating agent of the formula: R -CO-X (R is an alkyl or aryl group; X is Cl, Br, OH, an alkoxy group or OCOR where R is an alkyl or an aryl group) and an aromatic compound of the formula: H-Ar-(R )m (H is hydrogen atom; Ar is a monocyclic, polycyclic or heterocyclic aromatic residue where the polycyclic aromatic residue is connected with direct bonds; R is a hydrogen atom or an alkyl group) are allowed to react in vapor phase with each other in the presence of a zeolite ion-exchanged with a metal ion whereby an acylated aromatic compound of the formula: R -CO-Ar-(R )m (R , R , Ar and (m) have the same meanings as stated above) is obtained.
-
-
-
-
-
-
-
-
-